Bio-tech companies and drug-resistant bacteria
There is a feeling amongst small bio-tech companies that their skills are being overlooked in the initiatives being developed to confront the problem of drug-resistant bacteria. An alliance of 37 such companies across Europe have pledged to accelerate progress in dealing with this threat by bringing together expertise in the design and development of new …